DMAC DiaMedica Therapeutics Inc.
Executive Summary
Three mega-passive institutional investors (BlackRock, State Street, Morgan Stanley) collectively added $12.2M in DMAC during Q3 2025, while Vanguard trimmed $1.4M. The net $10.8M inflow from passive index rebalancing suggests no active fundamental thesis, consistent with the stock's small-cap pharma profile.
Key Financial Metrics
Institutional Positions
Net institutional flow: $10.8M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | ADD | +40.8% | $11.5M | $6.9M |
| State Street | ADD | +89.2% | $3.3M | $2.3M |
| Morgan Stanley | DOUBLED | +141% | $4.0M | $3.0M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Vanguard | TRIM | -56.7% | $6.0M | -$1.4M |
Actionable Insight
The cluster is entirely passive index rebalancing — no active manager conviction signal. Monitor for any active fund 13F filings (e.g., sector-specific healthcare funds) in subsequent quarters to gauge genuine institutional interest. The Vanguard trim is notable as a partial reversal of prior accumulation.
Key Facts
- 3 passive mega-funds added $12.2M in aggregate DMAC holdings during Q3 2025
- BlackRock increased position by 40.8% to $11.5M, the largest buyer
- Morgan Stanley doubled its position (+141%) to $4.0M
- Vanguard trimmed 56.7% of its position, reducing holdings by $1.4M to $4.6M
- All four funds are mega-passive index managers — no active hedge fund or activist involvement
- Net institutional inflow of ~$10.8M represents ~3.8% of DMAC's $287M market cap
Financial Impact
3 passive buyers added $12.2M in new positions while 1 passive seller reduced by $1.4M, for net institutional inflow of approximately $10.8M
Risk Factors
- Passive flows are mechanical and may reverse next quarter without fundamental catalyst
- 13F data is 45+ days stale; positions may have already been adjusted
- Small market cap ($287M) means even modest passive flows can distort ownership percentages
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-DMAC-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $5.32 awaiting T+20 | awaiting T+20 | — | — |
|
May 6, 2026
5w ago
|
8-K
| $6.53 $5.65 | ▲ +13.48% | ▲ +16.61% | — |
|
Apr 1, 2026
10w ago
|
DEFA14A
| $6.48 $6.05 | ▼ −6.64% | ▼ −16.51% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access